Sun hopes cut-price generic Gleevec will win third of U.S. market

ZURICH (Reuters) - India's Sun Pharma launched a generic version of Novartis's leukaemia drug Gleevec on Monday in the United States and hopes to poach a third of sales in six months by pricing the copycat some 30 percent cheaper, its Sun's North American chief executive said.

http://ift.tt/20CrEl3

from Reuters: Health News
via animenewspro